Neonatal arterial ischemic stroke is a common cause of cerebral palsy and other lifelong neurologic disabilities. Studies to date have been limited by modest sample sizes of regional and heterogeneous populations, limiting advances in understanding and treatment.
Perinatal stroke has emerged as a common cause of lifelong neurologic disability. Neonatal arterial ischemic stroke (AIS) is a common variety and is defined as acute symptomatic, focal cerebral infarction in an arterial territory between birth and 28 days of life that is confirmed by neuroimaging. 1, 2 Most survivors suffer neurologic morbidity, and perinatal stroke is the leading cause of hemiplegic cerebral palsy. 2 Many infants with AIS incur additional sequelae including impairments in language, cognition, and behavior and epilepsy. [3] [4] [5] Case-control data are limited, and little is understood regarding pathophysiology. 2, 6 That adverse outcomes last for decades amplifies the impact of neonatal AIS on patients, their families, and society.
Studies of neonatal AIS have been limited by sample size and inconsistent terminology, data collection, and riskfactor evaluations. The International Pediatric Stroke Study (IPSS) was established to standardize approaches to childhood stroke research on a global scale. Treatment options remain to be established, and practice patterns seem widely discrepant. 7 Consensus-based guidelines for pediatric stroke [8] [9] [10] offer little direction in neonatal AIS, and global practices regarding identification, investigation, and management must be established to facilitate systematic studies and clinical trials.
We examine here the presentations, clinical associations, investigations, treatments, and early outcomes of a large, global population of neonates with AIS.
METHODS

International Pediatric Stroke Study
The IPSS was established in 2003 by 11 coinvestigators including pediatric neurologists, hematologists, and epidemiologists. The long-term goal of the prospective registry was to develop and execute international clinical trials (https://app3.ccb.sickkids.ca/ cstrokestudy/). Prospective enrollment extended from January 1, 2003, to July 1, 2007 (149 coinvestigators, 30 centers, 10 countries) and included symptomatic neonatal AIS but not presumed perinatal ischemic strokes. The IPSS office (Hospital for Sick Children) managed Web-based data entry and the master database. Consensusbased definitions for diagnosis, investigations, outcomes, and treatment were applied. Study identification numbers were assigned at enrollment. Data were deidentified and entered into a password-protected, Web-based system. Clinical care was not prescribed by the IPSS. Methods were approved by site research ethics boards with informed consent. The complete IPSS methodology is described elsewhere. 11
Population
Cases were enrolled by site investigators using established clinical and radiographic criteria 5 including (1) acute neurologic deficit or seizure and (2) radiographic confirmation of acute focal cerebral infarction(s) within arterial territories corresponding to clinical manifestations. Infants with the following conditions were excluded: neonatal cerebral sinovenous thrombosis, 12 presumed perinatal ischemic stroke, intracranial hemorrhage, global hypoxic-ischemic injury, periventricular leukomalacia, and metabolic injury.
Data Abstraction
Investigators collected datademographics (age, gender, race/ethnicity, location), clinical presentations, imaging, potential risk factors and evaluations, treatments, and discharge outcomes-by using standardized forms. Age at diagnosis was expressed by postnatal week (ethical restrictions on birth dates). Neonates born at Յ36 or Ն41 weeks' gestation were considered to be premature or postmature, respectively. Investigational sites were grouped according to region (Europe, Canada, United States, South America, Asia, or Australia). Birth weight was trichotomized (Ͻ2500, 2500 -4000, or Ͼ4000 g). Season of event was adjusted according to hemisphere.
Potential risk factors were classified into consensus IPSS categories based on case-control studies and theoretical considerations only including cardiac, prothrombotic, acute and chronic illnesses, arteriopathy, and neonatal (maternal, pregnancy, neonatal, and obstetric). Neonates with systemic illness or significant resuscitation were classified as having "acute neonatal illness." Prothrombotic testing and investigator interpretation varied across institutions, hence the term "possible" prothrombotic abnormality. Treatment categories included antithrombotic, anticonvulsant, and other. Outcomes, discharge destination, and causes of death were recorded.
Analysis
Numerators were expressed over the available population unless otherwise stated. For each outcome of interest, variables predefined on evidence were compared ( 2 analysis, dichotomous; t tests, continuous) and expressed as odds ratios (ORs) with 95% confidence intervals (CIs). To determine independent predictors, multivariate logistic regression models incorporated univariate P values of Յ .1 with testing for colinearity. Stata 10.0 (College Station, TX) was used for statistical calculations.
neonates. Neonates with AIS totaled 248 and represented our population (71% of all neonates, 21% of all AISs). Median gestational age was 39.0 weeks (mean: 39.0 Ϯ 1.9; range: 31-42). Birth weight was considered normal (86%) or small (10%) or large (4%) for gestational age, and 55% had birth weights lower than the median for gestational age. Multiple (twin) gestations were uncommon (3 [1%] ). Nineteen of the infants were born prematurely (8%), and another 20 (10%) were born postmaturely. Gender was discrepant; 140 (57%) were male (detailed analysis described elsewhere). 11 Geographic origin of the patients was United States (51%), Europe (19%), Canada (16%), South America (6%), Australia (6%), or Asia (3%) (Fig 1) .
Clinical Presentations
Most patients presented in the first week of life (87%). Seizures were common at presentation (178 [72%]), as were diffuse neurologic signs (157 [63%]); the most common sign was abnormal tone (38%) or level of consciousness (39%). A minority of the patients demonstrated focal neurologic signs (30%), the majority of which were lateralizing hemiparesis (95%). Systemic findings included respiratory (26%) and feeding (24%) difficulties (Fig 2) .
Diagnosis and Neuroimaging
A brain MRI was obtained from nearly all of the infants (92%). Computed tomography (CT) scans were obtained for 119 (48%) infants. AIS lesions were single in 70% and isolated to the anterior circulation (71%), posterior circulation (9%), or both (20%). Strokes were more commonly left-sided (left alone in 51%, right alone in 25%), whereas bilateral lesions were observed in 24%. In those with only anterior circulation strokes, a strong leftsided preference was seen (73%).
Multiple vascular territory AIS was common (30%). In univariate analysis, associations with multiple-territory infarcts included neonatal resuscitation (OR: 4.58; P Ͻ .0001), maternal hypertension (OR: 4.29; P ϭ .006), and acute systemic illness (OR: 2.13; P ϭ .03). In multivariate analysis, only neonatal resuscitation was independently associated with multiple-territory infarction (OR: 5.5; P Ͻ .0001) ( Table 1) .
Intracranial hemorrhage in 56 neonates (23%) was reported. Most of 
FIGURE 2
Clinical presentations of neonatal AIS. Most neonates presented with seizures (dark), although diffuse neurologic signs (altered level of consciousness or tone) and systemic abnormalities (respiratory or feeding difficulties) were frequent. Fewer than 30% of the newborns were described as having focal neurologic deficits. AUS indicates Australia; CAN, Canada; SA, South America. them (62%) were classified as hemorrhage within the infarct (hemorrhagic transformation). In univariate analysis, associations with hemorrhagic transformation included acute systemic illness (OR: 18.78; P ϭ .008), acidosis (OR: 17.7; P ϭ .004), sepsis (OR: 21.5; P ϭ .002), and bilateral lesions (OR: 20.29; P ϭ .007). In multivariate analysis, only bilateral lesions remained an independent predictor (OR: 15.54; P ϭ 0. 03) ( Table 1) .
Arterial imaging was performed on 53% of the infants (magnetic resonance angiography in 49%). CT and conventional angiography were rare (4% and 3%, respectively). Abnormalities of arterial imaging were reported in 29 infants (12% overall, 22% of those imaged). Abnormal vascular imaging results included descriptions of arterial occlusion (9 [7%]) and possible arteriopathy (stenosis, dissection, or vasculitis) (10 [8%] ), but further details were not available. No associations with abnormal arterial imaging were identified.
Potential Risk factors
Median maternal age was 29 years (mean: 29.8 Ϯ 5.6; range: 16 -43). Fiftytwo percent of women were primiparous, and 15% were of advanced maternal age (Ն35 years). History of previous miscarriage was recorded for 27 of the mothers (11%). Diagnosis was not associated with month or season of birth. The majority of pregnancies were conceived naturally (144 of 159 [91%]). Family-history data were incomplete, but not a single case of perinatal stroke in a sibling was reported. Maternal medical conditions were uncommon with the exception of gestational hypertension and/or preeclampsia, reported in 10%. Factors such as gestational diabetes, oligohydramnios/polyhydramnios, and prenatal trauma, infections, or bleeding were each recorded in Ͻ1%.
Potential perinatal factors included maternal fever (9%), prolonged rupture of membranes (6%), and presence of meconium (23% 
DISCUSSION
To our knowledge, this is the first report of a large multinational cohort of newborns with symptomatic AIS. Our data include several clinically relevant findings. Our population was generally "sicker" than those in previous studies. Neonates with AIS are typically described as nonencephalopathic, otherwise well children who present at 1 to 2 days of life with seizures. 3, [13] [14] [15] However, at least 25% of our neonates showed signs of acute illness, including emergent cesarean delivery, resuscitation, low Apgar scores, and/or systemic illness. Despite this, the term "birth asphyxia" or suggestion of global hypoxic-ischemic encephalopathy was rare. Although they likely share risk factors and AIS can cooccur with hypoxic-ischemic encephalopathy, 16 most cases seemed to clearly distinguish the two. Such increased accuracy in diagnosis might reflect a combination of better neuroimaging (diffusion MRI), enhanced experience of the IPSS investigators, and better awareness of disease patterns. Such distinctions are essential for choosing investigations, treatment options, outcome prediction, family counseling, and research progress.
Neonates were unlikely to present with focal deficits, which emphasizes the need for a high index of clinical suspicion and prompt neuroimaging to diagnose stroke. Modern neuroimaging has greatly improved the detection and understanding of neonatal AIS. Our findings support the use of MRI with diffusion-weighted sequences as the first-line imaging modality in most cases of neonatal encephalopathy, which facilitates the accurate diagnosis of neonatal AIS. The role of CT scanning is limited and has little advantage over MRI but poses additional risk of radiation to the neonatal brain. 17 Our results have helped better characterize hemorrhagic changes associated with neonatal AIS. Associations with markers of acute disease suggest that systemic processes such as altered hemostatic mechanisms might increase the likelihood of intracranial bleeding. Although not evaluated in detail, severe hemorrhages that required a change in management were not reported. Therefore, repeat imaging for hemorrhagic changes might not be required, particularly with CT scanning. Addition of blood-sensitive magnetic resonance sequences (gradient echo, susceptibility-weighted images) is a viable alternative, and incorporation of such sequences to neonatal neuroimaging protocols might enhance our understanding of disease mechanisms.
Noninvasive vascular imaging is now routinely available and recommended by current pediatric stroke consensus guidelines. 8 Despite this, fewer than half of the neonates with AIS had cerebral angiographic studies performed. Furthermore, dedicated angiography of the cervical vasculature was rarely reported. Arterial dissection in neonates has been described and might represent an underrecognized entity with cervical imaging so underperformed. The documentation of arterial occlusion in Ͻ10% of the cases with angiographic studies suggests multiple possibilities. This finding is perhaps most consistent with systemic embolic events, although obvious risks for embolism are present in a small minority of patients (eg, congenital heart disease). In addition, recanalization of cerebral arteries might occur quickly, and with most imaging performed days after birth, occlusions might often not be evident. It is interesting to note that despite a very low number of cases, "arteriopathy" was associated with deficits at discharge (8 of 9 cases). Routine vascular imaging of the head and neck is required in neonatal stroke protocols to help resolve this issue.
Disordered coagulation has long been suspected of contributing to perinatal stroke. Previous case-control data for neonatal AIS are sparse, and estimates have varied widely (20%-68%). [18] [19] [20] [21] [22] Evidence does support a role for thrombophilia in neonatal AIS, particularly protein C deficiency, elevated lipoprotein(a) level, and factor V Leiden. 23 A 2010 meta-analysis of thrombophilia in pediatric stroke found only 22 of 185 studies eligible, and only 6 focused on "perinatal stroke." 23 The authors concluded that studies have been "contradictory or inconclusive due to lack of statistical power." 23 Additional limiting factors of these studies and ours include inconsistent laboratory methods with a lack of controls matched for perinatal factors including age, in which developmental changes in hemostasis are paramount and normative values are not well established. 24 Our results do little to resolve the poorly understood role of thrombophilia in neonatal AIS, and fully powered, carefully controlled studies are required.
Consistent with the controversial role of antithrombotic treatment for neonatal AIS, treatment was uncommon and varied according to region. Recent neonatal cerebral sinovenous thrombosis studies within the IPSS 12 and elsewhere 25 found similar international discrepancies in treatment. Current consensus-based guidelines [8] [9] [10] vary in their recommendations regarding neonatal AIS treatment, although they consistently support anticoagulation therapy in congenital heart disease, and such an association was observed here. Our study could not examine the safety or efficacy of such interventions, although serious complications were not reported, and no association with intracranial hem-orrhage was observed. Neonatal AIS carries an extremely low recurrence rate, 2 so withholding anticoagulation therapy would seem reasonable outside the circumstance of congenital heart disease. Antithrombotic clinical trials will not likely occur for neonatal AIS; neuroprotective interventions seem a more likely future focus.
Because most of the infants presented with seizures, the frequent use of anticonvulsants is expected. However, treatment seemed to be discontinued by discharge for most patients. This might parallel practices in other forms of neonatal encephalopathy (eg, hypoxic-ischemic encephalopathy), for which the natural history is better understood and early cessation of seizure medications might be reasonable. Stroke-induced neonatal seizures have been studied less, and the possibilities of both ongoing subclinical seizures and medication adverse effects need to be considered. Prospective studies of neonatal AIS seizure treatment including cerebral monitoring are required.
Our sample size provided a unique opportunity to perform multivariate logistic regression and generate speculative hypotheses regarding outcomes of interest. That presentation with acute focal deficits predicts the same at discharge is hardly surprising. However, could the association of neonatal resuscitation with multiple infarcts reflect underlying diseased placenta? Potential reasons for the independent association observed between hemorrhage and bilateral lesions are less evident, and a wide CI should be interpreted with caution. Currently minimal understanding of neonatal stroke pathophysiology suggests value in the consideration of such previously unreported associations. 
CONCLUSIONS
Interpretation of our neurologic outcome data are extremely limited. Because most neonates do not manifest obvious focal deficits and admission times are generally short, it is not surprising that those who do will still have discharge deficits. However, it is now well established that children will "grow into their deficits" after perinatal brain injury. Even simple motor outcomes (cerebral palsy) are not reasonably characterized until 18 to 24 months, whereas more complex deficits (eg, learning, behavioral) are often not appreciated until school age. 4, 28, 29 Therefore, our results should not be used to try to predict long-term neurologic outcomes in neonates with AIS, and the potential associations described here should be considered hypothesis-generating only. Fortunately, ongoing follow-up of this IPSS cohort will facilitate future studies to more accurately characterize neurologic outcomes.
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